Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Munsie

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
The Pharmacogenomics Journal|December 22, 2010
Pharmacogenetic analysis of the mGlu2/3 agonist LY2140023 monohydrate in the treatment of schizophreniaW Liu, A C M Downing, L M Munsie, et al.
Journal of the American Geriatrics Society|April 3, 2018
One-Year Effect of the Medicare Annual Wellness Visit on Detection of Cognitive Impairment: A Cohort StudyNicole R Fowler, Noll L Campbell, Gerhardt M Pohl, et al.
Neurology|February 22, 2024
Assessment of Efficacy and Safety of Zagotenemab: Results From PERISCOPE-ALZ, a Phase 2 Study in Early Symptomatic Alzheimer DiseaseAdam S Fleisher, Leanne M Munsie, David G S Perahia, et al.
Neuroepidemiology|November 18, 2014
Calibrating longitudinal cognition in Alzheimer's disease across diverse test batteries and datasetsAlden L Gross, Richard Sherva, Shubhabrata Mukherjee, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|February 26, 2019
Mutations in ILK, encoding integrin-linked kinase, are associated with arrhythmogenic cardiomyopathyAndreas Brodehl, Saman Rezazadeh, Tatjana Williams, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 22, 2015
Genetic studies of quantitative MCI and AD phenotypes in ADNI: Progress, opportunities, and plansAndrew J Saykin, Li Shen, Xiaohui Yao, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
The Pharmacogenomics Journal|December 22, 2010
Pharmacogenetic analysis of the mGlu2/3 agonist LY2140023 monohydrate in the treatment of schizophreniaW Liu, A C M Downing, L M Munsie, et al.
Journal of the American Geriatrics Society|April 3, 2018
One-Year Effect of the Medicare Annual Wellness Visit on Detection of Cognitive Impairment: A Cohort StudyNicole R Fowler, Noll L Campbell, Gerhardt M Pohl, et al.
Neurology|February 22, 2024
Assessment of Efficacy and Safety of Zagotenemab: Results From PERISCOPE-ALZ, a Phase 2 Study in Early Symptomatic Alzheimer DiseaseAdam S Fleisher, Leanne M Munsie, David G S Perahia, et al.
Neuroepidemiology|November 18, 2014
Calibrating longitudinal cognition in Alzheimer's disease across diverse test batteries and datasetsAlden L Gross, Richard Sherva, Shubhabrata Mukherjee, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|February 26, 2019
Mutations in ILK, encoding integrin-linked kinase, are associated with arrhythmogenic cardiomyopathyAndreas Brodehl, Saman Rezazadeh, Tatjana Williams, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 22, 2015
Genetic studies of quantitative MCI and AD phenotypes in ADNI: Progress, opportunities, and plansAndrew J Saykin, Li Shen, Xiaohui Yao, et al.
Pageof 2